The growth and evolution of cardiovascular magnetic resonance: a 20-year history of the Society for Cardiovascular Magnetic Resonance (SCMR) annual scientific sessions

Daniel C Lee, Michael Markl, Erica Dall'Armellina, Yuchi Han, Sebastian Kozerke, Titus Kuehne, Sonia Nielles-Vallespin, Daniel Messroghli, Amit Patel, Tobias Schaeffter, Orlando Simonetti, Anne Marie Valente, Jonathan W Weinsaft, Graham Wright, Stefan Zimmerman, Jeanette Schulz-Menger, Daniel C Lee, Michael Markl, Erica Dall'Armellina, Yuchi Han, Sebastian Kozerke, Titus Kuehne, Sonia Nielles-Vallespin, Daniel Messroghli, Amit Patel, Tobias Schaeffter, Orlando Simonetti, Anne Marie Valente, Jonathan W Weinsaft, Graham Wright, Stefan Zimmerman, Jeanette Schulz-Menger

Abstract

Background and purpose: The purpose of this work is to summarize cardiovascular magnetic resonance (CMR) research trends and highlights presented at the annual Society for Cardiovascular Magnetic Resonance (SCMR) scientific sessions over the past 20 years.

Methods: Scientific programs from all SCMR Annual Scientific Sessions from 1998 to 2017 were obtained. SCMR Headquarters also provided data for the number and the country of origin of attendees and the number of accepted abstracts according to type. Data analysis included text analysis (key word extraction) and visualization by 'word clouds' representing the most frequently used words in session titles for 5-year intervals. In addition, session titles were sorted into 17 major subject categories to further evaluate research and clinical CMR trends over time.

Results: Analysis of SCMR annual scientific sessions locations, attendance, and number of accepted abstracts demonstrated substantial growth of CMR research and clinical applications. As an international field of study, significant growth of CMR was documented by a strong increase in SCMR scientific session attendance (> 500%, 270 to 1406 from 1998 to 2017, number of accepted abstracts (> 700%, 98 to 701 from 1998 to 2018) and number of international participants (42-415% increase for participants from Asia, Central and South America, Middle East and Africa in 2004-2017). 'Word clouds' based evaluation of research trends illustrated a shift from early focus on 'MRI technique feasibility' to new established techniques (e.g. late gadolinium enhancement) and their clinical applications and translation (key words 'patient', 'disease') and more recently novel techniques and quantitative CMR imaging (key words 'mapping', 'T1', 'flow', 'function'). Nearly every topic category demonstrated an increase in the number of sessions over the 20-year period with 'Clinical Practice' leading all categories. Our analysis identified three growth areas 'Congenital', 'Clinical Practice', and 'Structure/function/flow'.

Conclusion: The analysis of the SCMR historical archives demonstrates a healthy and internationally active field of study which continues to undergo substantial growth and expansion into new and emerging CMR topics and clinical application areas.

Keywords: Archives; CMR; Cardiac; Heart; History; SCMR; Trends.

Conflict of interest statement

Ethics approval and consent to participate

Not applicable

Consent for publication

Not applicable

Competing interests

The authors declare that they have no competing interests.

Publisher’s note

This work represents an official publication of the SCMR and was approved by the SCMR Executive Committee. It did not undergo the customary JCMR peer-review process.

Figures

Fig. 1
Fig. 1
SCMR scientific sessions title pages from 1998 to 2017 illustrating a trend from basic to advanced CMR methods
Fig. 2
Fig. 2
20-year evolution of SCMR annual scientific session attendance and number of accepted abstracts to be presented at the SCMR scientific sessions. Sustained growths of both annual scientific sessions attendance and scientific contributions are clearly evident. The attendance number of the 2018 meeting were not available at the time of this analysis
Fig. 3
Fig. 3
a Changes in number of accepted abstracts by type over the past 20 years. b Relationship between number of SCMR annual scientific session attendees and number of accepted abstracts. c Development of ratio of attendance vs. accepted abstract over the past 20 years
Fig. 4
Fig. 4
Word clouds visualizing the frequency of words used in SCMR scientific session titles over the past 20 years. Session titles were grouped in 5-year intervals and represent most frequently used words in SCMR session titles from 1998 to 2002 (a), 2003–2007 (b), 2008–2012 (c), and 2013–2017 (d). Word clouds were created using Voyant Tools (http://voyant-tools.org/)
Fig. 5
Fig. 5
a Number of SCMR scientific session titles within major subject categories - trends over 20 years. b SCMR scientific session subject categories demonstrating “Super Growth” – defined as absolute growth ≥ 8 session titles over a 20-year time span. c SCMR scientific session subject categories demonstrating “Growth” – defined as absolute growth ≥ 4 session titles over a 20-year time span. d Several SCMR scientific session subject categories did not exist in the first time period, but exhibited significant growth in recent years

References

    1. Axel L, Otazo R. Accelerated MRI for the assessment of cardiac function. Br J Radiol. 2016;89:20150655. doi: 10.1259/bjr.20150655.
    1. Haaf P, Garg P, Messroghli DR, Broadbent DA, Greenwood JP, Plein S. Cardiac T1 mapping and extracellular volume (ECV) in clinical practice: a comprehensive review. J Cardiovasc Magn Reson. 2016;18:89. doi: 10.1186/s12968-016-0308-4.
    1. Kim RJ, Shah DJ, Judd RM. How we perform delayed enhancement imaging. J Cardiovasc Magn Reson. 2003;5:505–514. doi: 10.1081/JCMR-120022267.
    1. Kramer CM, Barkhausen J, Flamm SD, Kim RJ, Nagel E, Society for Cardiovascular Magnetic Resonance Board of Trustees Task Force on Standardized P Standardized cardiovascular magnetic resonance imaging (CMR) protocols, society for cardiovascular magnetic resonance: board of trustees task force on standardized protocols. J Cardiovasc Magn Reson. 2008;10:35. doi: 10.1186/1532-429X-10-35.
    1. Kramer CM, Barkhausen J, Flamm SD, Kim RJ, Nagel E, Society for Cardiovascular Magnetic Resonance Board of Trustees Task Force on Standardized P Standardized cardiovascular magnetic resonance (CMR) protocols 2013 update. J Cardiovasc Magn Reson. 2013;15:91. doi: 10.1186/1532-429X-15-91.
    1. Nayak KS, Nielsen JF, Bernstein MA, Markl M, Gatehouse P, Botnar R, Saloner D, Lorenz C, Wen H, Hu B, Epstein FH, J NO, Raman SV. Cardiovascular magnetic resonance phase contrast imaging. J Cardiovasc Magn Reson. 2015;17:71.
    1. Oshinski JN, Delfino JG, Sharma P, Gharib AM, Pettigrew RI. Cardiovascular magnetic resonance at 3.0 T: current state of the art. J Cardiovasc Magn Reson. 2010;12:55. doi: 10.1186/1532-429X-12-55.
    1. Salerno M, Kramer CM. Advances in parametric mapping with CMR imaging. JACC Cardiovasc Imaging. 2013;6:806–822. doi: 10.1016/j.jcmg.2013.05.005.
    1. Tsao J, Kozerke S. MRI temporal acceleration techniques. J Magn Reson Imaging. 2012;36:543–560. doi: 10.1002/jmri.23640.
    1. Tyler DJ, Hudsmith LE, Petersen SE, Francis JM, Weale P, Neubauer S, Clarke K, Robson MD. Cardiac cine MR-imaging at 3T: FLASH vs SSFP. J Cardiovasc Magn Reson. 2006;8:709–715. doi: 10.1080/10976640600723797.
    1. Friedrich MG. The future of cardiovascular magnetic resonance imaging. Eur Heart J. 2017;38:1698–1709. doi: 10.1093/eurheartj/ehx243.
    1. Bogaert J, Francone M. Cardiovascular magnetic resonance in pericardial diseases. J Cardiovasc Magn Reson. 2009;11:14. doi: 10.1186/1532-429X-11-14.
    1. Bradlow WM, Gibbs JS, Mohiaddin RH. Cardiovascular magnetic resonance in pulmonary hypertension. J Cardiovasc Magn Reson. 2012;14:6. doi: 10.1186/1532-429X-14-6.
    1. Butler CR, Thompson R, Haykowsky M, Toma M, Paterson I. Cardiovascular magnetic resonance in the diagnosis of acute heart transplant rejection: a review. J Cardiovasc Magn Reson. 2009;11:7. doi: 10.1186/1532-429X-11-7.
    1. Dormand H, Mohiaddin RH. Cardiovascular magnetic resonance in Marfan syndrome. J Cardiovasc Magn Reson. 2013;15:33. doi: 10.1186/1532-429X-15-33.
    1. Fieno DS, Saouaf R, Thomson LE, Abidov A, Friedman JD, Berman DS. Cardiovascular magnetic resonance of primary tumors of the heart: a review. J Cardiovasc Magn Reson. 2006;8:839–853. doi: 10.1080/10976640600777975.
    1. Francis SA, Daly C, Heydari B, Abbasi S, Shah RV, Kwong RY. Cost-effectiveness analysis for imaging techniques with a focus on cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2013;15:52. doi: 10.1186/1532-429X-15-52.
    1. Maceira AM, Mohiaddin RH. Cardiovascular magnetic resonance in systemic hypertension. J Cardiovasc Magn Reson. 2012;14:28. doi: 10.1186/1532-429X-14-28.
    1. Maron MS. Clinical utility of cardiovascular magnetic resonance in hypertrophic cardiomyopathy. J Cardiovasc Magn Reson. 2012;14:13. doi: 10.1186/1532-429X-14-13.
    1. Myerson SG. Heart valve disease: investigation by cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2012;14:7. doi: 10.1186/1532-429X-14-7.
    1. Ntsinjana HN, Hughes ML, Taylor AM. The role of cardiovascular magnetic resonance in pediatric congenital heart disease. J Cardiovasc Magn Reson. 2011;13:51. doi: 10.1186/1532-429X-13-51.
    1. Parsai C, O'Hanlon R, Prasad SK, Mohiaddin RH. Diagnostic and prognostic value of cardiovascular magnetic resonance in non-ischaemic cardiomyopathies. J Cardiovasc Magn Reson. 2012;14:54. doi: 10.1186/1532-429X-14-54.
    1. Petitjean C, Rougon N, Cluzel P. Assessment of myocardial function: a review of quantification methods and results using tagged MRI. J Cardiovasc Magn Reson. 2005;7:501–516. doi: 10.1081/JCMR-200053610.
    1. Raman SV, Aneja A, Jarjour WN. CMR in inflammatory vasculitis. J Cardiovasc Magn Reson. 2012;14:82. doi: 10.1186/1532-429X-14-82.
    1. Thornhill RE, Prato FS, Wisenberg G. The assessment of myocardial viability: a review of current diagnostic imaging approaches. J Cardiovasc Magn Reson. 2002;4:381–410. doi: 10.1081/JCMR-120013301.
    1. American College of Cardiology Foundation Task Force on Expert Consensus D, Hundley WG, Bluemke DA, Finn JP, Flamm SD, Fogel MA, Friedrich MG, Ho VB, Jerosch-Herold M, Kramer CM, Manning WJ, Patel M, Pohost GM, Stillman AE, White RD, Woodard PK. ACCF/ACR/AHA/NASCI/SCMR 2010 expert consensus document on cardiovascular magnetic resonance: a report of the American College of Cardiology Foundation task force on expert consensus documents. J Am Coll Cardiol. 2010;55:2614-2662.
    1. Dyverfeldt P, Bissell M, Barker AJ, Bolger AF, Carlhall CJ, Ebbers T, Francios CJ, Frydrychowicz A, Geiger J, Giese D, Hope MD, Kilner PJ, Kozerke S, Myerson S, Neubauer S, Wieben O, Markl M. 4D flow cardiovascular magnetic resonance consensus statement. J Cardiovasc Magn Reson. 2015;17:72. doi: 10.1186/s12968-015-0174-5.
    1. Mavrogeni SI, Kitas GD, Dimitroulas T, Sfikakis PP, Seo P, Gabriel S, Patel AR, Gargani L, Bombardieri S, Matucci-Cerinic M, Lombardi M, Pepe A, Aletras AH, Kolovou G, Miszalski T, van Riel P, Semb A, Gonzalez-Gay MA, Dessein P, Karpouzas G, Puntmann V, Nagel E, Bratis K, Karabela G, Stavropoulos E, Katsifis G, Koutsogeorgopoulou L, van Rossum A, Rademakers F, Pohost G, Lima JA. Cardiovascular magnetic resonance in rheumatology: current status and recommendations for use. Int J Cardiol. 2016;217:135-148.
    1. Messroghli DR, Moon JC, Ferreira VM, Grosse-Wortmann L, He T, Kellman P, Mascherbauer J, Nezafat R, Salerno M, Schelbert EB, Taylor AJ, Thompson R, Ugander M, van Heeswijk RB, Friedrich MG. Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2* and extracellular volume: a consensus statement by the Society for Cardiovascular Magnetic Resonance (SCMR) endorsed by the European Association for Cardiovascular Imaging (EACVI) J Cardiovasc Magn Reson. 2017;19:75. doi: 10.1186/s12968-017-0389-8.
    1. Moon JC, Messroghli DR, Kellman P, Piechnik SK, Robson MD, Ugander M, Gatehouse PD, Arai AE, Friedrich MG, Neubauer S, Schulz-Menger J, Schelbert EB, Society for Cardiovascular Magnetic Resonance I, Cardiovascular Magnetic Resonance Working Group of the European Society of C Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMR working Group of the European Society of cardiology consensus statement. J Cardiovasc Magn Reson. 2013;15:92. doi: 10.1186/1532-429X-15-92.
    1. Nagel E, Lorenz C, Baer F, Hundley WG, Wilke N, Neubauer S, Sechtem U, van der Wall E, Pettigrew R, de Roos A, Fleck E, van Rossum A, Pennell DJ, Wickline S. Stress cardiovascular magnetic resonance: consensus panel report. J Cardiovasc Magn Reson. 2001;3:267–281. doi: 10.1081/JCMR-100107475.
    1. Pennell DJ, Sechtem UP, Higgins CB, Manning WJ, Pohost GM, Rademakers FE, van Rossum AC, Shaw LJ, Yucel EK, European Society of c, Soceity for Cardiovascular Magnetic R Clinical indications for cardiovascular magnetic resonance (CMR): consensus panel report. J Cardiovasc Magn Reson. 2004;6:727–765. doi: 10.1081/JCMR-200038581.
    1. Schulz-Menger J, Bluemke DA, Bremerich J, Flamm SD, Fogel MA, Friedrich MG, Kim RJ, von Knobelsdorff-Brenkenhoff F, Kramer CM, Pennell DJ, Plein S, Nagel E. Standardized image interpretation and post processing in cardiovascular magnetic resonance: Society for Cardiovascular Magnetic Resonance (SCMR) board of trustees task force on standardized post processing. J Cardiovasc Magn Reson. 2013;15:35. doi: 10.1186/1532-429X-15-35.
    1. Friedrich MG, Kramer CM, Sodickson DK, Flamm SD, Buser P, Neubauer S, Scientific Program Committee of the Society for Cardiovascular Magnetic R Meeting highlights of the 10th annual scientific sessions of the Society for Cardiovascular Magnetic Resonance and 6th annual meeting of the working Group for Cardiovascular Magnetic Resonance of the European Society of Cardiology: Rome, Italy, February 2-4, 2007. J Am Coll Cardiol. 2007;50:983–987. doi: 10.1016/j.jacc.2007.06.004.
    1. Fratz S, Chung T, Greil GF, Samyn MM, Taylor AM, Valsangiacomo Buechel ER, Yoo SJ, Powell AJ. Guidelines and protocols for cardiovascular magnetic resonance in children and adults with congenital heart disease: SCMR expert consensus group on congenital heart disease. J Cardiovasc Magn Reson. 2013;15:51. doi: 10.1186/1532-429X-15-51.
    1. Hundley WG, Bluemke D, Bogaert JG, Friedrich MG, Higgins CB, Lawson MA, McConnell MV, Raman SV, van Rossum AC, Flamm S, Kramer CM, Nagel E, Neubauer S. Society for Cardiovascular Magnetic Resonance guidelines for reporting cardiovascular magnetic resonance examinations. J Cardiovasc Magn Reson. 2009;11:5. doi: 10.1186/1532-429X-11-5.
    1. Liu T, Pursnani A, Sharma UC, Vorasettakarnkij Y, Verdini D, Deeprasertkul P, Lee AM, Lumish H, Sidhu MS, Medina H, Danik S, Abbara S, Holmvang G, Hoffmann U, Ghoshhajra BB. Effect of the 2010 task force criteria on reclassification of cardiovascular magnetic resonance criteria for arrhythmogenic right ventricular cardiomyopathy. J Cardiovasc Magn Reson. 2014;16:47. doi: 10.1186/1532-429X-16-47.
    1. von Knobelsdorff-Brenkenhoff F, Pilz G, Schulz-Menger J. Representation of cardiovascular magnetic resonance in the AHA / ACC guidelines. J Cardiovasc Magn Reson. 2017;19:70. doi: 10.1186/s12968-017-0385-z.
    1. von Knobelsdorff-Brenkenhoff F, Schulz-Menger J. Role of cardiovascular magnetic resonance in the guidelines of the European Society of Cardiology. J Cardiovasc Magn Reson. 2016;18:6. doi: 10.1186/s12968-016-0225-6.

Source: PubMed

3
購読する